Nanoscope Therapeutics
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. They utilize ambient light-sensitive molecules to re-sensitize the retina toward a low light level. Its light-assisted gene therapy is highly targeted to geographic atrophies without perturbing the intact retina circuitry.
Domain
nanostherapeutics.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$1.5M
Founded
2016
Tech Stack (21 technologies)
Frequently Asked Questions
What technologies does Nanoscope Therapeutics use?+
Nanoscope Therapeutics uses 21 technologies including Elementor, ExactMetrics, Font Awesome.
What industry is Nanoscope Therapeutics in?+
Nanoscope Therapeutics operates in the Biotechnology industry.
Where is Nanoscope Therapeutics based?+
Nanoscope Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026